Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Syncope and presyncope
 
Major Surgical or Invasive Procedure:
___: PPM placement.
 
History of Present Illness:
HISTORY OF PRESENTING ILLNESS: ___ male with history of 
hypercholesterolemia presenting for presyncopal symptoms. 
Patient states he has had 3 episodes over the past year. Has had 
negative workups in the past including stress test, echo. Has a 
30 day event monitor and noted to 2 episodes of ___ second 
pauses. Cardiology referred him in for admission for pacemaker 
placement. Says that his symptoms always occur when he is eating 
foods. Does note that he hasn't been drinking much all day 
today. 

In the ED initial vitals were: 97.7 81 134/86 18 98% RA   
 EKG:  NSR, NA, NI no ischemic changes
 Labs/studies notable for: neg trop, cr 1.4, K 4.7  
 Vitals on transfer: 98.4 61 134/84 20 97% RA  
 On the floor reports feeling well. No lightheadedness, 
dizziness, chest pain, SOB.  

 
Past Medical History:
Dyslipidemia, obesity.
 
Social History:
___
Family History:
 Mother has h/o HTN, otherwise no family history of early MI, 
arrhythmia, cardiomyopathies, or sudden cardiac death. 
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS: BP:137/85 HR:62SR RR:18 O2 SAT 99RA  
GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.  

NECK: Supple with JVP not visible at 45 degrees.   
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RR, normal S1, S2. No murmurs/rubs/gallops. No thrills, 
lifts.  
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. No crackles, wheezes or 
rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: No c/c/e. 
SKIN: No rashes 
PULSES: Distal pulses palpable and symmetric 

DISCHARGE PHYSICAL EXAMINATION: 
Vitals: 98.7 ___ (briefly SBP ___ and triggered)
HR 50-90s (low as ___
GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.  

NECK: Supple with JVP not visible at 45 degrees.   
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RR, normal S1, S2. No murmurs/rubs/gallops. No thrills, 
lifts.  
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. No crackles, wheezes or 
rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: No c/c/e. 
SKIN: No rashes 
PULSES: Distal pulses palpable and symmetric 
 
Pertinent Results:
ADMISSION LABS
___ 07:45PM   WBC-6.8 RBC-4.73 HGB-14.3 HCT-43.8 MCV-93 
MCH-30.2 MCHC-32.6 RDW-12.6 RDWSD-42.9
___ 07:45PM   GLUCOSE-93 UREA N-22* CREAT-1.4* SODIUM-136 
POTASSIUM-4.7 CHLORIDE-102 TOTAL CO2-24 ANION GAP-15
___ 07:45PM   NEUTS-52.9 ___ MONOS-9.5 EOS-3.8 
BASOS-0.6 IM ___ AbsNeut-3.61 AbsLymp-2.24 AbsMono-0.65 
AbsEos-0.26 AbsBaso-0.04
___ 07:45PM   ___ PTT-32.4 ___
___ 07:45PM   cTropnT-<0.01

DISCHARGE LABS
___ 08:00AM BLOOD WBC-7.5 RBC-4.86 Hgb-15.2 Hct-45.2 MCV-93 
MCH-31.3 MCHC-33.6 RDW-12.8 RDWSD-44.0 Plt ___
___ 08:00AM BLOOD Glucose-96 UreaN-17 Creat-1.1 Na-137 
K-4.4 Cl-102 HCO3-23 AnGap-16

STUDIES
CXR ___
IMPRESSION:  
  
Status post placement of dual lead pacer as detailed above, with 
no visible pneumothorax. 

PACEMAKER PLACEMENT:
Successful implantation of dual chamber pacemaker via the left 
cephalic without complications.

 
Brief Hospital Course:
 Mr. ___ is a ___ male with history of 
hypercholesterolemia presenting for PPM placement for 
presyncope.

 #Sick sinus syndrome and nodal arrest on holter monitor: 
Mr. ___ had 3 prior syncopal episodes s/p extensive workup 
including stress test, echo, all of which were normal. His 
holter monitor w/ nodal arrest, 4.8 sec pause with presyncopal 
symptoms. He was admitted for PPM placement. Telemetry and ECG 
revealed sinus bradycardia. PPM was placed on ___. Patient had 
a trigger for SBPs in 60-70s and HR in ___ briefly with 
lightheadedness, dizziness, diaphoresis. Likely ___ vasovagal 
episode and exacerbated by anesthetics (fentanyl, versed) for 
procedure and NPO status x 18 hrs prior to procedure. Patient 
shortly after paced at HR > 100 and then returned to normal 
heart rates in 60-70s. EP aware and interrogated pacemaker and 
found to be functional. Patient without symptoms following brief 
episode. Deemed stable for discharge.

Will follow up with device clinic, cardiology, and PCP.

 #Hyperlipidemia - Added rosuvastatin 40mg qpm. 

 ___ - Initially, Cr 1.4, with baseline normal. Likely prerenal 
from decreased fluid intake. Resolved morning after admission. 
Cr at 1.0 at discharge.

================= 
TRANSITIONAL ISSUES:  
=================
TRANSITIONAL
=============
-Added statin as a new medication given findings of 
hyperlipidemia.
-Pt will need a follow-up appointment with Dr. ___ 
pacemaker evaluation in ___ weeks.

 # CODE: Full code (confirmed) 
 # CONTACT: ___ (wife) ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. This patient is not taking any preadmission medications

 
Discharge Medications:
1.  Rosuvastatin Calcium 40 mg PO QPM  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
PRESYNCOPE W/ NODAL ARREST S/P PACEMAKER PLACEMENT

SECONDARY:
HYPERLIPIDEMIA

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr. ___,

You were admitted for a pacemaker placement. Your pacemaker was 
evaluated by the electrophysiology team to be stable. It was 
interrogated while you were hospitalized. You will follow-up 
with Dr. ___ in ___ weeks.

You were started on atorvastatin, a new medicine to lower your 
cholesterol, which you should take daily.

If you experience new symptoms, lightheadedness, dizziness, 
shortness of breath, chest pain, please return for further 
evaluation. 
It was a pleasure taking care of you!

Your ___ Team
 
                             ___ MD ___
 
Completed by: ___